A glutamatergic ventrolateral periaqueductal gray-lateral habenula pathway is associated with depression-like behavioral measures in young adult male mice with trigeminal neuropathic pain Authors: Lulu Zhang, Yizhen Yao, Chengmao Zhou, Minhui Wu, Fucheng Zhang, Jiwei Yao, He Zhu Published: 2026 ABSTRACT BackgroundDepression is a clinically important comorbidity of trigeminal pain disorders, including trigeminal neuralgia, yet the neural circuits linking persistent trigeminal nerve injury to negative affect remain incompletely understood. The present study aimed to investigate the involvement of the ventrolateral periaqueductal gray (vlPAG)-lateral habenula (LHb) pathway in depression-like behavioral measures in a young adult male mouse model of trigeminal neuropathic pain.MethodsA mouse model of trigeminal neuropathic pain was established in young adult male mice using infraorbital nerve chronic constriction injury (IoN-CCI). Spontaneous facial pain-related behavior and depression-like behavioral measures were assessed using facial grooming analysis, the sucrose preference test, the open field test, and the tail suspension test. c-Fos mapping, cell-type analysis, viral tracing, and chemogenetic manipulation of vlPAG glutamatergic neurons and the vlPAG-LHb pathway were performed to examine neuronal recruitment, anatomical connectivity, and behavioral relevance.ResultsIn young adult male mice, IoN-CCI induced persistent facial grooming behavior as an index of spontaneous facial pain-related behavior and, by 4 weeks after surgery, was associated with depression-like behavioral changes without detectable alterations in body weight, general locomotor activity, or hindpaw mechanical and thermal sensitivity. c-Fos mapping and cell-type analyses showed a progressive increase in c-Fos expression in vlPAG neurons following IoN-CCI, with most labeled neurons identified as glutamatergic, suggesting recruitment of vlPAG glutamatergic neurons in this model. Chemogenetic inhibition of vlPAG glutamatergic neurons decreased depression-like behavioral measures, whereas chemogenetic activation increased these measures, without significantly altering facial grooming behavior used as an index of spontaneous facial pain-related behavior. Viral tracing provided anatomical evidence for a projection from the vlPAG to the LHb, and c-Fos expression in LHb neurons increased following IoN-CCI. Chemogenetic inhibition of the vlPAG-LHb pathway decreased depression-like behavioral measures, whereas chemogenetic activation increased these measures in IoN-CCI mice and was associated with similar behavioral changes in naive mice.ConclusionThese findings suggest that the vlPAG-LHb pathway is functionally associated with behavioral measures related to negative affect in a young adult male mouse model of trigeminal neuropathic pain, providing a circuit-level framework for understanding pain-associated affective disturbances.Clinical trial numberNot applicable.Graphical Abstract Supplementary InformationThe online version contains supplementary material available at 10.1186/s10194-026-02415-x. Background Depression frequently co-occurs with chronic pain, and their relationship is complex and bidirectional, with each capable of exacerbating the other [1]. This comorbidity poses a major challenge for clinical management. Epidemiological studies indicate that approximately 65% of patients with depression experience pain symptoms, whereas the prevalence of depression among individuals with chronic pain ranges from 5% to 85% [2]. This high rate of co-occurrence markedly impairs quality of life. Accumulating evidence suggests that chronic pain and depression share overlapping neuroplastic changes, as well as partially convergent neural circuits and neurotransmitter systems within the central nervous system, including serotonergic and noradrenergic pathways [2, 3]. Consistent with this view, antidepressants have demonstrated analgesic efficacy in both clinical and experimental settings [4]. Among chronic pain conditions, trigeminal neuralgia is characterized by severe pain intensity, recurrent facial attacks, and substantial emotional burden. Clinical observations indicate that patients with trigeminal neuralgia frequently exhibit depressive symptoms and other affective disturbances, highlighting the contribution of negative emotional states to disease burden [5]. Recent advances in neural circuit research have provided insights into the mechanisms linking persistent pain to negative affect. The periaqueductal gray (PAG), particularly its ventrolateral subdivision (vlPAG), is a major node in descending pain modulation and has also been implicated in stress-related and affective processing [6]. Chemogenetic activation of vesicular glutamate transporter 2 (VGLUT2)-expressing neurons in the vlPAG has been shown to produce analgesic effects [7], and optogenetic stimulation of vlPAG glutamatergic neurons has been reported to reduce nociceptive hypersensitivity and anxiety-like behaviors induced by chronic sciatic nerve ligation [8]. These findings indicate functional heterogeneity within the PAG and suggest that the vlPAG may be involved not only in nociceptive regulation but also in the emotional consequences of chronic pain. In parallel, the lateral habenula (LHb) is a key structure involved in the regulation of negative emotional states, aversive behavior, and reward processing [9]. Functional imaging studies have shown habenular hyperactivity in patients with major depressive disorder [10, 11]. The LHb has been proposed as an integrative node in pain-related affective processing, receiving nociceptive information and, through its extensive connectivity with multiple brain regions, influencing both descending pain control and emotional responses to pain [12, 13]. Mounting evidence supports an association between abnormal LHb activity and affective disturbances in chronic pain states, suggesting that the LHb may serve as a downstream substrate linking persistent nociceptive signals to depression-related behaviors. Although previous studies have independently characterized the role of the vlPAG in nociceptive modulation and the involvement of the LHb in affective encoding, the functional relevance of interactions between these regions in pain-associated depression remains unclear. Notably, both emotional stress and persistent pain states have been shown to activate vlPAG neurons [14, 15], suggesting that this region may influence affective and cognitive behaviors through downstream pathways. In trigeminal pain conditions, circuit-level analyses of depression-like behaviors have begun to identify pathways linking chronic pain to negative affect [16], but whether specific projections involving the vlPAG and LHb participate in this process remains unknown. In the present study, we used an infraorbital nerve chronic constriction injury (IoN-CCI) [17] model of trigeminal neuropathic pain. Viral tracing, chemogenetic manipulation, and behavioral analyses were combined to investigate the functional involvement of the vlPAG-LHb pathway in pain-associated depression-like behavioral measures. Given the clinical distinctions between traumatic trigeminal neuropathic pain and classical trigeminal neuralgia, this study was not intended to recapitulate the full clinical phenotype of trigeminal neuralgia, but rather to examine a circuit-level framework through which persistent trigeminal nerve injury may be associated with affective-related behavioral changes. Materials and methods Animals Young adult male C57BL/6J mice (6–10 weeks old) were purchased from Guangdong Skjinda Biotechnology Co., Ltd. Vglut2-IRES-Cre transgenic mice (stock no. 000664) were obtained from The Jackson Laboratory. All experiments were conducted in young adult male mice. All experimental procedures were approved by the Animal Ethics Committee of Central People’s Hospital of Zhanjiang (approval no. DW-2024026-01) and were conducted in accordance with institutional guidelines for the care and use of laboratory animals and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Mice were housed in groups of 4–5 per cage under controlled conditions (23–25 °C, 50–60% humidity) on a 12 h light-dark cycle, with food and water available ad libitum. Before behavioral testing, mice were acclimated to the experimental environment for at least 24 h. Infraorbital nerve chronic constriction injury (IoN-CCI) The IoN-CCI model was established as previously described [17]. Mice were anesthetized with sodium pentobarbital (50 mg/kg, i.p.). The surgical site was disinfected with iodophor. A small incision was made between the eye and the nose to expose the unilateral infraorbital nerve, a branch of the trigeminal nerve that emerges from the infraorbital foramen and innervating the whisker pad. The exposed infraorbital nerve was ligated distal to the infraorbital foramen using a 5 − 0 chromic gut suture. The incision was then sutured, and the wound was disinfected again. Mice in the sham group underwent the same procedure, including nerve exposure, without ligation. Viral injection Mice were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and placed in a stereotaxic frame. Small burr holes were drilled in the skull. All viral vectors used in this study were obtained from Wuhan BrainVTA Co., Ltd. Viral suspensions were injected into the indicated brain regions at a volume of 100–400 nL per site using a calibrated glass micropipette connected to a microinjection pump (RWD Life Science, Shenzhen, China) and a 1 µL Hamilton microsyringe at a rate of 50 nL/min. The micropipette was left in place for 5–10 min after injection to allow diffusion and minimize backflow. For vlPAG injection, the stereotaxic coordinates were AP -4.72 mm, ML -0.50 mm, and DV -2.80 mm. For LHb injection, the stereotaxic coordinates were AP -1.70 mm, ML -0.40 mm, and DV -2.20 mm. Coordinates were defined relative to bregma for the anteroposterior axis, the midline for the mediolateral axis, and the brain surface for the dorsoventral axis. Detailed information on viral constructs used in each experiment is provided in the corresponding sections. Neuronal projection tracing For anterograde tracing, the cre-dependent virus rAAV-EF1a-DIO-EGFP-WPRE-hGH polyA (AAV2/5, 5.45 × 10¹² vg/mL, 100 nL) was injected into the vlPAG of Vglut2-Cre mice. To further verify the vlPAG-LHb projection, rAAV-hSyn-Cre-WPRE-hGH polyA (AAV2/1, 1.09 × 10¹³ vg/mL, 100 nL) was injected into the vlPAG of C57BL/6J mice, and rAAV-EF1a-DIO-EGFP-WPRE-hGH polyA (AAV2/5, 5.45 × 10¹² vg/mL, 100 nL) was injected into the ipsilateral LHb. For retrograde tracing, ScAAV-hSyn-EGFP-WPREs (AAV2/R, 5.36 × 10¹² vg/mL, 100 nL) was injected into the LHb of C57BL/6J mice. Chemogenetic manipulation Local chemogenetic manipulation of vlPAG glutamatergic neurons To manipulate vlPAG glutamatergic neurons, C57BL/6J mice received stereotaxic injections of rAAV-EF1a-DIO-hM4Di-EGFP-WPRE-hGH polyA (AAV2/5, 5.85 × 10¹² vg/mL), rAAV-EF1a-DIO-hM3Dq-EGFP-WPRE-hGH polyA (AAV2/5, 5.40 × 10¹² vg/mL), or rAAV-EF1a-DIO-EGFP-WPRE-hGH polyA (AAV2/5, 5.05 × 10¹² vg/mL) together with rAAV-VGLUT2-Cre-WPRE-hGH polyA (AAV2/5, 1.02 × 1013 vg/mL) into the vlPAG. AAV-DIO viruses were co-injected with AAV-vglut2-Cre at a ratio of 2:1, and a total volume of 200 nL per site was injected. Viral expression was allowed for 3 weeks before behavioral testing. Clozapine-N-oxide (CNO, 3 mg/kg, i.p.) was administered prior to behavioral experiments. Behavioral testing was conducted in the following order: sucrose preference test (30 min after CNO injection), open field test (24 h later), and tail suspension test. Projection-specific chemogenetic manipulation of the vlPAGVGLUT2-LHb projection To manipulate vlPAG glutamatergic projections to the LHb, rAAV-EF1a-DIO-hM4Di-EGFP-WPRE-hGH polyA (AAV2/5, 5.85 × 10¹² vg/mL, 100 nL), rAAV-EF1a-DIO-hM3Dq-EGFP-WPRE-hGH polyA (AAV2/5, 5.40 × 10¹² vg/mL, 100 nL), or rAAV-EF1a-DIO-EGFP-WPRE-hGH polyA (AAV2/5, 5.05 × 10¹² vg/mL, 100 nL) was injected into the vlPAG, and rAAV-VGLUT2-Cre-WPRE-hGH polyA (AAV2/R, 5.09 × 1012 vg/mL, 100 nL) was injected into the ipsilateral LHb. Viral expression was allowed for 3 weeks before behavioral testing. CNO (3 mg/kg, i.p.) was administered prior to behavioral experiments. Behavioral testing was conducted in the same order as described above. Immunohistochemistry Mice were deeply anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and transcardially perfused with ice-cold phosphate-buffered saline (PBS), followed by 4% paraformaldehyde (PFA) in PBS. Brains were collected, postfixed overnight in 4% PFA at 4 °C, and cryoprotected sequentially in 10%, 20%, and 30% sucrose solutions. Coronal brain sections (40 μm) were prepared using a cryostat. Sections were blocked in 10% goat serum containing 0.3% Triton X-100 for 1 h at room temperature and then incubated with rabbit anti-c-Fos primary antibody (Cell Signaling Technology, #2250, 1:500) at 4 °C for 24 h. After washing with PBS, sections were incubated with goat anti-rabbit Alexa Fluor 488 secondary antibody (Invitrogen, A11008, 1:200) for 1 h at room temperature. Images were acquired using a Nikon A1 confocal microscope (Nikon, Japan) at 20× magnification under identical acquisition settings within each experiment. For quantification, the same number of matched coronal sections containing the region of interest was collected from each mouse. Fos-positive neurons and virus-labeled neurons were manually counted in predefined regions of interest. Quantitative analyses were performed using the raw cell counts obtained from the selected sections, with the number of quantified sections indicated in the corresponding figure legends. RNAscope in situ hybridization RNAscope in situ hybridization was performed using the RNAscope Multiplex Fluorescent Assay (Advanced Cell Diagnostics) according to the manufacturer’s instructions. Fresh-frozen brain sections (10 μm) were mounted onto slides, pretreated, and hybridized with probes against VGLUT2 (Advanced Cell Diagnostics, 319171) and Gad1 (Advanced Cell Diagnostics, 319191) at 40 °C. After sequential signal amplification, sections were labeled with fluorescent dyes and counterstained with DAPI. Images were acquired using a Nikon A1 confocal microscope (Nikon, Japan) at 20× magnification under identical acquisition settings within each experiment. For quantification, the same number of matched coronal sections containing the region of interest was collected from each mouse. Fos-labeled neurons and VGLUT2- or Gad1-positive neurons were manually counted in predefined regions of interest. For co-localization analyses, double-labeled cells were counted in the selected sections, and the percentage of double-labeled cells was calculated based on the raw counts from these sections. The number of quantified sections is indicated in the corresponding figure legends. Behavioral assessment of neuropathic pain and depression-like behaviors Mice used for behavioral testing were transferred to the testing room at least 24 h before the experiments to allow acclimation to the environment. Behavioral tests were conducted during the light phase under consistent environmental conditions. Animal behavior was recorded using a video tracking system. All behavioral analyses were performed by experimenters blinded to group assignment. Face-grooming behavior Mice were placed individually in a semi-transparent testing chamber and allowed to habituate for 1 h. Facial grooming behavior was recorded during a 2 min observation period and quantified as grooming frequency (strokes/min). This measure was used as an index of spontaneous facial pain-related behavior rather than evoked trigeminal sensory sensitivity. Grooming events were defined as forepaw movements directed toward the facial region, according to previously described criteria [18]. Sucrose preference test Mice were single-housed and provided with two bottles, one containing 1% sucrose solution and the other containing tap water. Mice were allowed to adapt to the two-bottle choice paradigm for 12 h, followed by reversal of bottle positions for an additional 12 h to minimize side preference. Animals were then deprived of water, but not food, for 24 h. During the subsequent 12 h test period, both bottles were made freely accessible. Fluid consumption were measured by weighing the bottles before and after the test. Sucrose preference was calculated as the percentage of sucrose intake relative to total fluid intake. Open field test Exploratory behavior was assessed in an open field arena (50 × 50 cm) for 5 min. Animal movements were recorded using the VisuTrack system. Locomotor activity was evaluated based on total distance traveled and average velocity. The time spent in the center of the arena was used as a measure of center exploration. The apparatus was cleaned with 75% ethanol after each trial to eliminate residual odors. Tail suspension test Mice were suspended by the tail using adhesive tape placed approximately 1 cm from the tip and hung from a horizontal bar 30 cm above the floor. Each mouse was tested once for 6 min. Behavior was recorded and analyzed using the VisuTrack system. Immobility time was quantified as the total duration of immobility during the test period, defined as the absence of initiated movements except for passive swaying. Hindpaw mechanical and thermal sensitivity Hindpaw mechanical and thermal sensitivity was assessed as a measure of generalized somatic sensitivity. These assays were not designed to assess trigeminal-region evoked nociceptive responses. For mechanical sensitivity testing, mice were placed individually in transparent chambers on an elevated metal mesh platform and allowed to habituate for 30 min. Calibrated von Frey filaments were applied perpendicularly to the plantar surface of the hind paw until the filament bent slightly and was maintained for 2–3 s. A positive response was defined as rapid paw withdrawal, licking, or shaking. The 50% paw withdrawal threshold was calculated as an index of hindpaw mechanical sensitivity. For thermal sensitivity testing, mice were placed individually in chambers on a glass surface and allowed to acclimate for 30 min. A focused radiant heat stimulus was applied to the plantar surface of the hind paw, and paw withdrawal latency was recorded. A cutoff time of 20 s was used to avoid tissue damage. Each paw was tested multiple times with sufficient intervals between stimuli, and the mean value was used for statistical analysis. Statistical analysis All data are presented as mean ± SEM. Statistical analyses were performed using GraphPad Prism 10 (GraphPad Software, USA), and figures were prepared using Adobe Illustrator. Normality was assessed before statistical testing. For comparisons between two groups, paired or unpaired Student’s t-tests were used as appropriate when data were normally distributed. For comparisons among three or more groups, ordinary one-way ANOVA followed by Bonferroni post hoc test was used when the variance assumption was satisfied. When unequal variances were detected among multiple groups, Welch’s ANOVA followed by Dunnett’s T3 multiple comparisons test was used. For comparisons involving multiple factors, two-way ANOVA followed by Bonferroni post hoc test was used. For behavioral data collected across different time points, two-way repeated-measures ANOVA followed by Bonferroni post hoc test was applied where appropriate. For data that did not meet the assumption of normality, nonparametric tests, including the Mann–Whitney U test or Wilcoxon signed-rank test, were used as appropriate. Statistical significance is indicated as *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Results IoN-CCI induces persistent facial grooming behavior and delayed depression-like behavioral changes Following IoN-CCI, behavioral changes were assessed over time, including facial grooming behavior and depression-like behavioral measures (Fig. 1A and B). Facial grooming behavior, used here as an index of spontaneous facial pain-related behavior, was quantified by its frequency [18]. Following IoN-CCI surgery, mice showed increased facial grooming frequency beginning on the first postoperative day. This behavior persisted throughout the observation period (Fig. 1C). Body weight remained stable over time in IoN-CCI mice (sFig. 1A and B). Sham-operated mice showed no increase in facial grooming frequency and no significant change in body weight (Fig. 1C; sFig. 1B). Fig. 1IoN-CCI induces facial grooming and delayed depression-like behavioral changes. (A) Representative images of the IoN-CCI procedure. (B) Schematic illustration of the experimental design. (C) Frequency of facial grooming behavior, used as an index of spontaneous facial pain-related behavior, after IoN-CCI or sham surgery. n = 10 per group, ***P < 0.001, two-way repeated-measures ANOVA followed by Bonferroni post hoc test. (D, E) Sucrose preference at 1 week (D) and 4 weeks (E) after surgery. n = 7 per group at 1 week; n = 10 per group at 4 weeks, **P < 0.01, unpaired Student’s t-test. (F–J) Total distance traveled, mean velocity, time spent in the center of the open field, and immobility time in the tail suspension test at 1 week after IoN-CCI surgery. n = 7 per group, ns, unpaired Student’s t-test. (K–O) Total distance traveled, mean velocity, time spent in the center of the open field, and immobility time in the tail suspension test at 4 weeks after IoN-CCI surgery. n = 10 per group, **P < 0.01, ***P < 0.001, unpaired Student’s t-test. Data are presented as mean ± SEM IoN-CCI induces facial grooming and delayed depression-like behavioral changes. (A) Representative images of the IoN-CCI procedure. (B) Schematic illustration of the experimental design. (C) Frequency of facial grooming behavior, used as an index of spontaneous facial pain-related behavior, after IoN-CCI or sham surgery. n = 10 per group, ***P < 0.001, two-way repeated-measures ANOVA followed by Bonferroni post hoc test. (D, E) Sucrose preference at 1 week (D) and 4 weeks (E) after surgery. n = 7 per group at 1 week; n = 10 per group at 4 weeks, **P < 0.01, unpaired Student’s t-test. (F–J) Total distance traveled, mean velocity, time spent in the center of the open field, and immobility time in the tail suspension test at 1 week after IoN-CCI surgery. n = 7 per group, ns, unpaired Student’s t-test. (K–O) Total distance traveled, mean velocity, time spent in the center of the open field, and immobility time in the tail suspension test at 4 weeks after IoN-CCI surgery. n = 10 per group, **P < 0.01, ***P < 0.001, unpaired Student’s t-test. Data are presented as mean ± SEM Depression-like behavioral measures were evaluated at 1 and 4 weeks after IoN-CCI surgery. At 1 week, no significant differences were observed between IoN-CCI and sham mice in sucrose preference (Fig. 1D), time spent in the center of the open field (Fig. 1F–I), or immobility time in the tail suspension test (Fig. 1J). At 4 weeks after surgery, IoN-CCI mice showed reduced sucrose preference (Fig. 1E), decreased time spent in the center of the open field (Fig. 1K–N), and increased immobility time in the tail suspension test (Fig. 1O). Total distance traveled and average velocity in the open field test were comparable between IoN-CCI and sham mice at both time points. IoN-CCI mice also showed no significant differences in hindpaw mechanical withdrawal threshold or hindpaw thermal withdrawal latency (sFig. 1 C–H). These hindpaw assays were used to assess generalized somatic sensitivity and did not directly evaluate trigeminal-region evoked nociceptive responses. IoN-CCI progressively increases c-Fos expression in vlPAG neurons, with glutamatergic neurons predominating among c-Fos-positive cells c-Fos immunostaining in the vlPAG showed a progressive increase in the number of c-Fos-positive neurons at 1 and 4 weeks after IoN-CCI (Fig. 2A–C). To further characterize the neuronal identity of cells labeled by the Fos-dependent strategy, Fos-CreERT2 mice were used to label neurons recruited during the later phase after IoN-CCI. One week after IoN-CCI surgery, AAV-DIO-EGFP was injected into the vlPAG, and tamoxifen was administered intraperitoneally for 4 consecutive days at 4 weeks after surgery to label Fos-expressing neurons, followed by in situ hybridization analysis (Fig. 2D–E). Quantitative analysis showed that approximately 80% of Fos-labeled neurons colocalized with VGLUT2, whereas approximately 20% colocalized with GABAergic markers (Fig. 2F–G). Fig. 2IoN-CCI increases vlPAG c-Fos expression, with Fos-labeled cells predominantly VGLUT2-positive. (A) Schematic illustration of the IoN-CCI procedure and experimental design. (B) Quantification of c-Fos-positive neurons in the vlPAG at different time points. n = 12 sections from 4 mice per group, ***P < 0.001, Welch’s ANOVA followed by Dunnett’s T3 multiple comparisons test. (C) Representative images of c-Fos-positive neurons in the vlPAG at different time points. (D, E) Schematic illustration and timeline of Fos-dependent labeling in Fos-CreERT2 mice following AAV-DIO-EGFP injection into the vlPAG 7 days after IoN-CCI surgery. (F) Representative high-magnification images showing colocalization of Fos-labeled cells with VGLUT2 or GABAergic markers in the vlPAG. Boxed regions are enlarged in the lower panels. Yellow arrows indicate Fos-labeled/VGLUT2 colocalization, and white arrows indicate Fos-labeled/GABAergic marker colocalization. (G) Quantification of Fos-labeled cell colocalization in the vlPAG. n = 12 sections from 4 mice per group, ****P < 0.0001, unpaired Student’s t-test. Data are presented as mean ± SEM IoN-CCI increases vlPAG c-Fos expression, with Fos-labeled cells predominantly VGLUT2-positive. (A) Schematic illustration of the IoN-CCI procedure and experimental design. (B) Quantification of c-Fos-positive neurons in the vlPAG at different time points. n = 12 sections from 4 mice per group, ***P < 0.001, Welch’s ANOVA followed by Dunnett’s T3 multiple comparisons test. (C) Representative images of c-Fos-positive neurons in the vlPAG at different time points. (D, E) Schematic illustration and timeline of Fos-dependent labeling in Fos-CreERT2 mice following AAV-DIO-EGFP injection into the vlPAG 7 days after IoN-CCI surgery. (F) Representative high-magnification images showing colocalization of Fos-labeled cells with VGLUT2 or GABAergic markers in the vlPAG. Boxed regions are enlarged in the lower panels. Yellow arrows indicate Fos-labeled/VGLUT2 colocalization, and white arrows indicate Fos-labeled/GABAergic marker colocalization. (G) Quantification of Fos-labeled cell colocalization in the vlPAG. n = 12 sections from 4 mice per group, ****P < 0.0001, unpaired Student’s t-test. Data are presented as mean ± SEM Bidirectional chemogenetic manipulation of vlPAG glutamatergic neurons alters depression-like behavioral measures Chemogenetic manipulation of vlPAG glutamatergic neurons was performed to examine their behavioral relevance in IoN-CCI mice. IoN-CCI was induced in C57BL/6J mice, and one week later, AAV-DIO-hM4Di-EGFP, AAV-DIO-hM3Dq-EGFP, or AAV-DIO-EGFP was co-injected with AAV-Vglut2-Cre into the vlPAG (Fig. 3A, B, and J; sFig. 3A and B). Immunofluorescence confirmed the expression of viral constructs in vlPAGVGLUT2 neurons (Fig. 3C and K; sFig. 3C). After three weeks of viral expression, mice received CNO (3 mg/kg, i.p.). Behavioral tests were then conducted, with the sucrose preference test performed 30 min after CNO administration, followed by the open field test 24 h later and the tail suspension test thereafter. In situ hybridization performed after behavioral testing showed that approximately 80% of virus-labeled neurons were VGLUT2-positive (sFig. 2 A and B). Fig. 3Bidirectional chemogenetic manipulation of vlPAG glutamatergic neurons alters depression-like behavioral measures. (A) Schematic illustration of the experimental design. (B) Seven days after IoN-CCI surgery, a mixture of AAV-DIO-hM4Di-EGFP and AAV-Vglut2-Cre was injected into the vlPAG of C57BL/6J mice. (C) Schematic illustration of viral injection sites in the vlPAG. (D) Sucrose preference after chemogenetic inhibition of vlPAGVGLUT2 neurons in IoN-CCI mice. (E–H) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic inhibition of vlPAGVGLUT2 neurons in IoN-CCI mice. (I) Immobility time in the tail suspension test after chemogenetic inhibition of vlPAGVGLUT2 neurons in IoN-CCI mice. For (D–I), n = 6 mice, *P < 0.05, **P < 0.01, paired Student’s t-test. (J) Seven days after IoN-CCI surgery, a mixture of AAV-DIO-hM3Dq-EGFP and AAV-Vglut2-Cre was injected into the vlPAG of C57BL/6J mice. (K) Schematic illustration of viral injection sites in the vlPAG. (L) Sucrose preference after chemogenetic activation of vlPAGVGLUT2 neurons in IoN-CCI mice. (M–P) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic activation of vlPAGVGLUT2 neurons in IoN-CCI mice. (Q) Immobility time in the tail suspension test after chemogenetic activation of vlPAGVGLUT2 neurons in IoN-CCI mice. For (L–Q), n = 12 mice, **P < 0.01, ***P < 0.001, paired Student’s t-test. Data are presented as mean ± SEM Bidirectional chemogenetic manipulation of vlPAG glutamatergic neurons alters depression-like behavioral measures. (A) Schematic illustration of the experimental design. (B) Seven days after IoN-CCI surgery, a mixture of AAV-DIO-hM4Di-EGFP and AAV-Vglut2-Cre was injected into the vlPAG of C57BL/6J mice. (C) Schematic illustration of viral injection sites in the vlPAG. (D) Sucrose preference after chemogenetic inhibition of vlPAGVGLUT2 neurons in IoN-CCI mice. (E–H) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic inhibition of vlPAGVGLUT2 neurons in IoN-CCI mice. (I) Immobility time in the tail suspension test after chemogenetic inhibition of vlPAGVGLUT2 neurons in IoN-CCI mice. For (D–I), n = 6 mice, *P < 0.05, **P < 0.01, paired Student’s t-test. (J) Seven days after IoN-CCI surgery, a mixture of AAV-DIO-hM3Dq-EGFP and AAV-Vglut2-Cre was injected into the vlPAG of C57BL/6J mice. (K) Schematic illustration of viral injection sites in the vlPAG. (L) Sucrose preference after chemogenetic activation of vlPAGVGLUT2 neurons in IoN-CCI mice. (M–P) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic activation of vlPAGVGLUT2 neurons in IoN-CCI mice. (Q) Immobility time in the tail suspension test after chemogenetic activation of vlPAGVGLUT2 neurons in IoN-CCI mice. For (L–Q), n = 12 mice, **P < 0.01, ***P < 0.001, paired Student’s t-test. Data are presented as mean ± SEM Chemogenetic inhibition of vlPAGVGLUT2 neurons increased sucrose preference in IoN-CCI mice (Fig. 3D). In the open field test, total distance traveled and average velocity were unchanged, whereas time spent in the center of the open field increased following CNO administration (Fig. 3E–H). In the tail suspension test, mice injected with AAV-DIO-hM4Di-EGFP showed reduced immobility time (Fig. 3I). No comparable changes were observed in control virus groups (sFig. 3D–I). Chemogenetic activation of vlPAGVGLUT2 neurons reduced sucrose preference (Fig. 3L), decreased time spent in the center of the open field (Fig. 3M–P), and increased immobility time in the tail suspension test (Fig. 3Q). Total distance traveled and average velocity in the open field test were unchanged. CNO administration did not significantly alter facial grooming behavior in IoN-CCI mice (sFig. 3 J–M). Projections from the vlPAG to the LHb are identified, and LHb c-Fos expression increases after IoN-CCI Anatomical projections between the vlPAG and the LHb were examined using multiple viral tracing approaches. For anterograde tracing of vlPAG glutamatergic projections, AAV-DIO-EGFP was injected into the vlPAG of Vglut2-Cre mice (Fig. 4A). EGFP-positive fibers were observed in the ipsilateral LHb, providing anatomical evidence for a vlPAG-to-LHb projection (Fig. 4B). In a complementary tracing approach, wild-type C57BL/6J mice received AAV2/1-Cre injection into the vlPAG and AAV-DIO-EGFP injection into the ipsilateral LHb (Fig. 4C). EGFP-positive neuronal somata were detected in the LHb, further supporting anatomical connectivity between the vlPAG and LHb (Fig. 4D). Retrograde tracing was then performed by injecting AAV-Retro-EGFP and CTB555 into the LHb of wild-type mice. Immunofluorescence confirmed tracer expression in the LHb (sFig. 2 C and D), and retrogradely labeled neuronal somata were identified in the vlPAG (Fig. 4F), providing additional anatomical evidence for vlPAG-to-LHb projections. Fig. 4vlPAG-to-LHb projections and increased LHb c-Fos expression after IoN-CCI. (A) Anterograde tracing of vlPAG glutamatergic projections by AAV-DIO-EGFP injection into the vlPAG of Vglut2-Cre mice. (B) Representative images of viral tracing. Left, viral injection site in the vlPAG. Middle, labeled projections in the ipsilateral LHb. Right, high-magnification image of projection fibers in the LHb. (C) AAV2/1-Cre was injected into the vlPAG, and AAV-DIO-EGFP was injected into the ipsilateral LHb of C57BL/6J mice. (D) Representative image showing EGFP-positive neuronal somata in the LHb. (E) Retrograde tracing by injection of AAV-retro-EGFP and CTB555 into the LHb. (F) Representative image showing retrogradely labeled neuronal somata in the vlPAG. (G) Schematic overview of the IoN-CCI surgery and subsequent LHb c-Fos analysis. (H) Quantification of c-Fos-positive neurons in the LHb at different time points. n = 6 sections from 3 mice per group, ***P < 0.001, one-way ANOVA followed by Bonferroni multiple comparisons test. (I) Representative images of c-Fos-positive neurons in the LHb at different time points. Data are presented as mean ± SEM vlPAG-to-LHb projections and increased LHb c-Fos expression after IoN-CCI. (A) Anterograde tracing of vlPAG glutamatergic projections by AAV-DIO-EGFP injection into the vlPAG of Vglut2-Cre mice. (B) Representative images of viral tracing. Left, viral injection site in the vlPAG. Middle, labeled projections in the ipsilateral LHb. Right, high-magnification image of projection fibers in the LHb. (C) AAV2/1-Cre was injected into the vlPAG, and AAV-DIO-EGFP was injected into the ipsilateral LHb of C57BL/6J mice. (D) Representative image showing EGFP-positive neuronal somata in the LHb. (E) Retrograde tracing by injection of AAV-retro-EGFP and CTB555 into the LHb. (F) Representative image showing retrogradely labeled neuronal somata in the vlPAG. (G) Schematic overview of the IoN-CCI surgery and subsequent LHb c-Fos analysis. (H) Quantification of c-Fos-positive neurons in the LHb at different time points. n = 6 sections from 3 mice per group, ***P < 0.001, one-way ANOVA followed by Bonferroni multiple comparisons test. (I) Representative images of c-Fos-positive neurons in the LHb at different time points. Data are presented as mean ± SEM c-Fos immunostaining was performed in the LHb at 1 and 4 weeks after IoN-CCI surgery to assess neuronal recruitment in this region (Fig. 4G). The number of c-Fos-positive neurons in the LHb increased at 1 week and further increased at 4 weeks after surgery (Fig. 4H and I). Projection-specific manipulation of vlPAGVGLUT2-LHb projection bidirectionally alters depression-like behavioral measures Projection-specific chemogenetic manipulation of the vlPAGVGLUT2-LHb projection was performed to examine its behavioral relevance in IoN-CCI mice. IoN-CCI was established in C57BL/6J mice. One week later, AAV-DIO-hM4Di-EGFP, AAV-DIO-hM3Dq-EGFP, or AAV-DIO-EGFP was injected into the vlPAG, and Retro-Vglut2-Cre was injected into the ipsilateral LHb (Fig. 5A, B, and J; sFig. 4 A and B). Immunofluorescence analysis confirmed the expression of viral constructs in LHb-projecting vlPAG glutamatergic neurons (Fig. 5C and K; sFig. 4 C). After three weeks of viral expression, mice received CNO (3 mg/kg, i.p.). Behavioral tests were then conducted, with the sucrose preference test performed 30 min after CNO administration, followed by the open field test 24 h later and the tail suspension test thereafter. Fig. 5Bidirectional manipulation of the vlPAGVGLUT2-LHb projection alters depression-like behavioral measures. (A) Schematic overview of experimental procedures. (B) Seven days after IoN-CCI surgery, C57BL/6J mice received stereotaxic injections of AAV-DIO-hM4Di-EGFP into the vlPAG and Retro-Vglut2-Cre into the ipsilateral LHb. (C) Schematic illustration of viral injection sites in the vlPAG. (D) Sucrose preference after chemogenetic inhibition of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. (E–H) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic inhibition of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. (I) Immobility time in the tail suspension test after chemogenetic inhibition of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. For (D, F, G, I), n = 8 mice; for (H), n = 7 mice; *P < 0.05, **P < 0.01, ***P < 0.001, paired Student’s t-test. (J) Seven days after IoN-CCI surgery, C57BL/6J mice received stereotaxic injections of AAV-DIO-hM3Dq-EGFP into the vlPAG and Retro-Vglut2-Cre into the ipsilateral LHb. (K) Schematic illustration of viral injection sites in the vlPAG. (L) Sucrose preference after chemogenetic activation of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. (M–P) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic activation of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. (Q) Immobility time in the tail suspension test after chemogenetic activation of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. For (L–Q), n = 8 mice, *P < 0.05, paired Student’s t-test. Data are presented as mean ± SEM Bidirectional manipulation of the vlPAGVGLUT2-LHb projection alters depression-like behavioral measures. (A) Schematic overview of experimental procedures. (B) Seven days after IoN-CCI surgery, C57BL/6J mice received stereotaxic injections of AAV-DIO-hM4Di-EGFP into the vlPAG and Retro-Vglut2-Cre into the ipsilateral LHb. (C) Schematic illustration of viral injection sites in the vlPAG. (D) Sucrose preference after chemogenetic inhibition of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. (E–H) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic inhibition of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. (I) Immobility time in the tail suspension test after chemogenetic inhibition of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. For (D, F, G, I), n = 8 mice; for (H), n = 7 mice; *P < 0.05, **P < 0.01, ***P < 0.001, paired Student’s t-test. (J) Seven days after IoN-CCI surgery, C57BL/6J mice received stereotaxic injections of AAV-DIO-hM3Dq-EGFP into the vlPAG and Retro-Vglut2-Cre into the ipsilateral LHb. (K) Schematic illustration of viral injection sites in the vlPAG. (L) Sucrose preference after chemogenetic activation of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. (M–P) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic activation of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. (Q) Immobility time in the tail suspension test after chemogenetic activation of the vlPAGVGLUT2-LHb projection in IoN-CCI mice. For (L–Q), n = 8 mice, *P < 0.05, paired Student’s t-test. Data are presented as mean ± SEM Chemogenetic inhibition of the vlPAGVGLUT2-LHb projection increased sucrose preference in IoN-CCI mice (Fig. 5D). In the open field test, total distance traveled and average velocity were unchanged, whereas time spent in the center of the open field increased after chemogenetic inhibition (Fig. 5E–H). In the tail suspension test, mice expressing hM4Di showed reduced immobility time (Fig. 5I). No comparable changes were observed in control virus groups (sFig. 4D–I). Chemogenetic activation of the vlPAGVGLUT2-LHb projection reduced sucrose preference (Fig. 5L), decreased time spent in the center of the open field (Fig. 5M–P), and increased immobility time in the tail suspension test (Fig. 5Q). Total distance traveled and average velocity in the open field test were unchanged. Chemogenetic manipulation of this projection did not significantly alter facial grooming behavior in IoN-CCI mice (sFig. 4 J–M). Chemogenetic activation of the vlPAGVGLUT2-LHb projection alters behavioral measures in naive mice Chemogenetic activation of the vlPAGVGLUT2-LHb projection was performed to examine its behavioral relevance in naive mice. Wild-type C57BL/6J mice received AAV-DIO-hM3Dq-EGFP injection into the vlPAG and Retro-Vglut2-Cre injection into the ipsilateral LHb (Fig. 6A and B). Immunofluorescence confirmed the expression of the viral construct in LHb-projecting vlPAG glutamatergic neurons (Fig. 6C). After three weeks of viral expression, mice received CNO (3 mg/kg, i.p.). Behavioral tests were then conducted, with the sucrose preference test performed 30 min after CNO administration, followed by the open field test 24 h later and the tail suspension test thereafter (Fig. 6A). Fig. 6Activation of the vlPAGVGLUT2-LHb projection alters behavioral measures in naive mice. (A) Schematic illustration of viral injections and the experimental timeline. (B) AAV-DIO-hM3Dq-EGFP was injected into the vlPAG of C57BL/6J mice, and Retro-Vglut2-Cre was injected into the ipsilateral LHb. (C) Schematic illustration of viral injection sites in the vlPAG. (D) Sucrose preference after chemogenetic activation of the vlPAGVGLUT2-LHb projection in naive mice. (E–H) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic activation of the vlPAGVGLUT2-LHb projection in naive mice. (I) Immobility time in the tail suspension test after chemogenetic activation of the vlPAGVGLUT2-LHb projection in naive mice. For (D–I), n = 12 mice, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, paired Student’s t-test. Data are presented as mean ± SEM Activation of the vlPAGVGLUT2-LHb projection alters behavioral measures in naive mice. (A) Schematic illustration of viral injections and the experimental timeline. (B) AAV-DIO-hM3Dq-EGFP was injected into the vlPAG of C57BL/6J mice, and Retro-Vglut2-Cre was injected into the ipsilateral LHb. (C) Schematic illustration of viral injection sites in the vlPAG. (D) Sucrose preference after chemogenetic activation of the vlPAGVGLUT2-LHb projection in naive mice. (E–H) Total distance traveled, mean velocity, and time spent in the center of the open field after chemogenetic activation of the vlPAGVGLUT2-LHb projection in naive mice. (I) Immobility time in the tail suspension test after chemogenetic activation of the vlPAGVGLUT2-LHb projection in naive mice. For (D–I), n = 12 mice, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, paired Student’s t-test. Data are presented as mean ± SEM Chemogenetic activation of the vlPAGVGLUT2-LHb projection reduced sucrose preference in naive mice (Fig. 6D). In the open field test, total distance traveled, average velocity, and time spent in the center of the open field decreased following CNO administration (Fig. 6E–H). In the tail suspension test, mice expressing hM3Dq showed increased immobility time (Fig. 6I). Discussion The present study suggests that the vlPAG-LHb glutamatergic pathway is functionally associated with depression-like behavioral measures in a young adult male mouse model of trigeminal neuropathic pain. Using the IoN-CCI model in young adult male mice, we found that persistent trigeminal nerve injury induced sustained facial grooming behavior as an index of spontaneous facial pain-related behavior and was associated with delayed-onset and sustained depression-like behavioral changes, without detectable alterations in body weight, general locomotor activity, or hindpaw mechanical and thermal sensitivity under the present testing conditions. This behavioral profile indicates that the model did not produce detectable generalized somatic nociceptive sensitization under the present testing conditions, while being accompanied by behavioral changes indicative of affective disturbance following trigeminal nerve injury in young adult male mice. Previous clinical studies have reported a high prevalence of depression and anxiety in patients with trigeminal neuralgia [19, 20], although the severity of affective disturbances is not always linearly correlated with pain intensity [21, 22]. These clinical observations provide a relevant context for studying pain-related affective symptoms, but they should not be taken to imply that the present young male IoN-CCI model fully recapitulates the clinical, age-related, or sex-related features of human trigeminal pain disorders. In this context, the phenotype observed in the present young male IoN-CCI model captures one experimentally tractable aspect of trigeminal neuropathic pain-associated affective disturbance, in which persistent facial pain-related behavior is accompanied by behavioral measures related to negative affect. Moreover, the delayed emergence of depression-like behavioral changes following persistent trigeminal nerve injury suggests that these affective-related behaviors may involve progressive central changes rather than simply reflecting an immediate consequence of nociceptive input. A notable feature of the present model is the apparent divergence between spontaneous facial pain-related behavior and hindpaw-based generalized somatic sensory readouts under the present experimental conditions. Commonly used peripheral nerve injury models, such as spared nerve injury (SNI) [23], chronic constriction injury (CCI) [24], and partial sciatic nerve ligation (PSNL) [25], often involve robust somatic nociceptive hypersensitivity and broader stress-related adaptations, which may contribute to depression-like behavioral phenotypes in these models [26–28]. By comparison, the IoN-CCI model used in the present study was associated with sustained facial grooming behavior, used here as an index of spontaneous facial pain-related behavior, together with delayed depression-like behavioral changes, in the absence of detectable hindpaw mechanical or thermal sensitization under the present testing conditions. This pattern suggests that trigeminal nerve injury may be accompanied by affective-related behavioral changes without detectable generalized hindpaw sensitization under the present testing conditions; however, it does not establish whether evoked trigeminal-region hypersensitivity was present. Accordingly, this pattern supports the possibility that affective-related behavioral changes following trigeminal nerve injury involve central circuit-related processes associated with affective regulation, while the contribution of trigeminal-region evoked hypersensitivity remains to be determined. This interpretation provides an experimental framework for studying how persistent trigeminal nerve injury may engage affective regulatory circuits, but it should not be taken to imply that the sensory phenotype of human trigeminal pain disorders is fully captured by the present behavioral assays. At the central level, c-Fos expression in vlPAG neurons progressively increased following trigeminal nerve injury. At the stage when depression-like behavioral changes were evident, glutamatergic neurons represented the predominant population among c-Fos-positive cells. These findings indicate preferential recruitment of vlPAG glutamatergic neurons, as reflected by c-Fos expression, but do not directly define neuronal firing dynamics or synaptic activity. Together, these observations are consistent with the broader view that the PAG, beyond its role in descending pain modulation, may also participate in behavioral processes related to negative affect during persistent pain [29, 30]. Consistent with this perspective, accumulating evidence indicates that PAG functions extend beyond sensory modulation to include stress adaptation, defensive behavior, and affective processing [31, 32]. Our data are consistent with this broader framework and further suggest that glutamatergic vlPAG neurons are recruited in association with depression-like behavioral changes in this model of trigeminal neuropathic pain. Functionally, chemogenetic inhibition of vlPAG glutamatergic neurons was associated with increased sucrose preference and reduced immobility time in IoN-CCI mice, whereas chemogenetic activation of these neurons produced opposite changes across depression-like behavioral measures. No significant change was detected in facial grooming behavior, which was used here as an index of spontaneous facial pain-related behavior under the present testing conditions. This pattern suggests that experimentally manipulated vlPAG glutamatergic neurons may be more closely associated with behavioral measures related to affective disturbance than with the pain-related behavioral readout assessed in this study, consistent with previous reports implicating PAG-related pathways in affective processing [8, 28]. In this context, identifying downstream regions anatomically linked to the vlPAG and potentially associated with affective-related behaviors is of particular interest. The LHb is widely recognized as a structure involved in aversive processing, negative reward signaling, and depression-related neural processes [33]. Consistent with these roles, we observed increased c-Fos expression in LHb neurons at later time points after IoN-CCI, coinciding with the emergence of depression-like behavioral changes. Although accumulating evidence indicates that LHb hyperactivity is associated with both chronic pain and depression [28, 34], the upstream pathways through which the LHb may be recruited in pain-depression comorbidity remain incompletely understood [35]. In the present study, viral tracing provided anatomical evidence for vlPAG-to-LHb projections. Together, these observations suggest that both regions show increased c-Fos expression at stages when depression-like behavioral changes are present in this model, supporting neuronal recruitment rather than direct evidence of firing dynamics or circuit output. To further examine the behavioral relevance of this anatomically defined pathway, projection-specific chemogenetic manipulation was performed. Chemogenetic inhibition of the vlPAGVGLUT2-LHb projection was associated with increased sucrose preference and reduced immobility time, whereas chemogenetic activation produced opposite changes across depression-like behavioral measures in mice with trigeminal neuropathic pain and partially similar behavioral changes in naive mice. Compared with models such as SNI, in which depression-like behaviors are thought to involve distributed network interactions [36], the present findings identify the vlPAGVGLUT2-LHb projection as one anatomically defined pathway functionally associated with depression-like behavioral measures in the IoN-CCI model. Notably, chemogenetic manipulation of this projection did not significantly alter facial grooming behavior, suggesting that the vlPAGVGLUT2-LHb projection, under the present experimental manipulation, may be more closely associated with behavioral measures related to affective disturbance than with the nociceptive behavioral readout assessed in this study. Taken together, the present findings support the view that trigeminal neuropathic pain in this model is associated with increased c-Fos expression in the vlPAG and LHb, with Fos-labeled vlPAG cells predominantly colocalizing with VGLUT2, along with the behavioral changes observed in this study. These observations provide a functional circuit-level context for understanding the association between chronic pain and depression-like behavioral changes, while not directly defining neuronal firing dynamics, synaptic function, or circuit output. From a translational perspective, these findings suggest that affective-related behavioral changes in trigeminal neuropathic pain may involve neural processes beyond those underlying nociceptive transmission alone, although this interpretation remains limited by the young male mouse model and the absence of direct circuit activity measurements [37]. Although the present study provides evidence for the functional involvement of the vlPAG-LHb pathway in depression-like behavioral measures in a young adult male mouse model of trigeminal neuropathic pain, several limitations should be acknowledged. First, all experiments were conducted in young adult male mice, which limits the generalizability of the findings across sexes and ages, as well as to the broader clinical population with trigeminal pain disorders. Given the well-established sex differences in pain processing and affective behaviors, the absence of female cohorts precludes conclusions about whether the vlPAG-LHb pathway is similarly involved in female mice. Trigeminal-region evoked nociceptive responses were not directly assessed in the present study. Facial grooming behavior was used as an index of spontaneous facial pain-related behavior under the present experimental conditions, whereas hindpaw mechanical and thermal assays were used to evaluate generalized somatic sensitivity rather than trigeminal sensory processing. Therefore, the present data do not allow us to determine the extent to which IoN-CCI produced evoked mechanical or thermal hypersensitivity within the trigeminal region. Several circuit-level questions also remain unresolved. The present analysis focused on vlPAG glutamatergic neurons, whereas other vlPAG neuronal populations and their potential contributions were not systematically examined. In addition, the specific LHb neuronal subtypes receiving vlPAG projections were not identified. Although chemogenetic manipulation revealed behavioral effects associated with the vlPAGVGLUT2-LHb projection, the cellular properties of vlPAG neurons, the synaptic mechanisms underlying vlPAG-LHb communication, and downstream circuit outputs remain to be determined. Similarly, c-Fos expression reflects neuronal engagement or recruitment rather than direct measurement of neuronal firing dynamics, synaptic transmission, or circuit output. Future studies incorporating electrophysiological recordings, in vivo calcium imaging or fiber photometry, projection-specific synaptic analyses, and circuit-output measurements will be important for defining the activity dynamics and synaptic mechanisms of this pathway. Inclusion of female cohorts will also be necessary to determine sex-dependent and sex-independent features of the vlPAG-LHb pathway in relation to pain-associated behavioral changes. Conclusions In conclusion, the present study shows that trigeminal neuropathic pain in young adult male mice is associated with increased c-Fos expression in the vlPAG and LHb, with Fos-labeled vlPAG cells predominantly colocalizing with VGLUT2, along with depression-like behavioral changes observed in this model. Chemogenetic manipulation of these neurons and their projections was associated with bidirectional changes across behavioral measures related to negative affect. These findings provide a functional circuit-level context for understanding pain-related depression-like behavioral changes within the limits of this young adult male mouse model. However, direct neuronal activity dynamics, synaptic mechanisms, circuit outputs, and trigeminal-region evoked nociceptive responses remain to be defined. A schematic summary of the findings is presented in Fig. 7. Fig. 7Schematic summary of the main findings. In young adult male mice, infraorbital nerve chronic constriction injury (IoN-CCI) was associated with sustained facial grooming behavior, used as an index of spontaneous facial pain-related behavior, and delayed depression-like behavioral changes. These behavioral changes were accompanied by increased c-Fos expression in the vlPAG and LHb, and Fos-labeled cells in the vlPAG predominantly colocalized with VGLUT2. Chemogenetic manipulation of vlPAG glutamatergic neurons and the vlPAGVGLUT2-LHb projection was associated with bidirectional changes across behavioral measures related to negative affect, without significantly altering facial grooming behavior under the present testing conditions Schematic summary of the main findings. In young adult male mice, infraorbital nerve chronic constriction injury (IoN-CCI) was associated with sustained facial grooming behavior, used as an index of spontaneous facial pain-related behavior, and delayed depression-like behavioral changes. These behavioral changes were accompanied by increased c-Fos expression in the vlPAG and LHb, and Fos-labeled cells in the vlPAG predominantly colocalized with VGLUT2. Chemogenetic manipulation of vlPAG glutamatergic neurons and the vlPAGVGLUT2-LHb projection was associated with bidirectional changes across behavioral measures related to negative affect, without significantly altering facial grooming behavior under the present testing conditions Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1